CSN3 and endothelial dysfunction: Furthermore, several studies indicate that the aglycone apigenin can reduce endothelial dysfunction due to its antioxidant action [11] and induce vasodilation via mechanisms that include the release of endothelial NO, a reduction of calcium influx into vascular smooth muscle, and the activation of KCa channels [10,13].